Paris, France — 20 May 2025 — Genèse Labs has added RG80, RG100 and the syringe-type RG55S to its RG Body Filler line. Building on RG60®, the company’s first in-house product launched in 2023, practitioners can now select from four formats according to treatment area and volume.

• Launch of RG80 (80 ml), RG100 (100 ml) and RG55S (55 ml syringe)

• All formats are monophasic gels based on 100% cross-linked hyaluronic acid

• Volume options optimised for large-area treatments improve procedural efficiency

• RG55S offers a syringe format for more precise and comfortable injection

Since the launch of RG60®, practitioners have asked for a wider range of options to match treatment-area size and target volume. With this expansion, the RG series becomes a body-contouring family of four products sharing the same technical foundation but differing in volume, concentration and format.

RG55S presents the formulation in a practical yet refined syringe design, enabling safer, more precise and more comfortable injection. By reducing transfer from vial to syringe, it simplifies preparation and elevates the treatment experience for practitioners and patients alike.

Body contouring requires far greater volumes than facial treatment. RG80 and RG100 are designed to reduce vial changes within a single session and keep the procedure flowing smoothly, and can be applied — in accordance with local regulations — to a range of body areas including hip volume, silhouette refinement, calf-line refinement and smoothing of skin-surface irregularities.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, hyaluronic acid fillers and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.